HIV-1 cell entry and advances in viral entry inhibitor therapy

被引:52
作者
Cooley, LA
Lewin, SR [1 ]
机构
[1] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia
[2] Royal Melbourne Hosp, Victorian Infect Dis Reference Lab, Parkville, Vic 3050, Australia
[3] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia
关键词
HIV-1 cell entry; HIV-1 entry inhibitor; HIV-1 fusion inhibitor; antiretroviral therapy;
D O I
10.1016/S1386-6532(02)00111-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Despite the considerable successes of highly active antiretroviral therapy, new classes of therapeutic agents are still urgently needed. Unfortunately, the emergence of antiviral resistance and drug toxicity remain challenging obstacles to successful treatment in many HIV-1-infected individuals. HIV-1 entry is a multi-step process that is an attractive target for the development of new classes of therapeutic agents. Considerable progress has been made in the understanding of HIV-1 cell entry, enabling the design of specific agents that can inhibit each step of cellular entry. A number of promising agents have commenced clinical trials, including the attachment inhibitor PRO 542, co-receptor inhibitor AMD3100 and fusion inhibitor T-20. A greater number of HIV-1 entry inhibitors are in preclinical development. This review outlines the mechanisms involved in HIV-1 entry and the sites,of action of specific HIV-1 inhibitors. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:121 / 132
页数:12
相关论文
共 47 条
  • [1] EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMER THAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES
    ALLAWAY, GP
    DAVISBRUNO, KL
    BEAUDRY, GA
    GARCIA, EB
    WONG, EL
    RYDER, AM
    HASEL, KW
    GAUDUIN, MC
    KOUP, RA
    MCDOUGAL, JS
    MADDON, PJ
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) : 533 - 539
  • [2] OLIGOMERIZATION OF THE HYDROPHOBIC HEPTAD REPEAT OF GP41
    BERNSTEIN, HB
    TUCKER, SP
    KAR, SR
    MCPHERSON, SA
    MCPHERSON, DT
    DUBAY, JW
    LEBOWITZ, J
    COMPANS, RW
    HUNTER, E
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (05) : 2745 - 2750
  • [3] The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
    Bleul, CC
    Farzan, M
    Choe, H
    Parolin, C
    ClarkLewis, I
    Sodroski, J
    Springer, TA
    [J]. NATURE, 1996, 382 (6594) : 829 - 833
  • [4] DENDRITIC CELLS EXPOSED TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMIT A VIGOROUS CYTOPATHIC INFECTION TO CD4+ T-CELLS
    CAMERON, PU
    FREUDENTHAL, PS
    BARKER, JM
    GEZELTER, S
    INABA, K
    STEINMAN, RM
    [J]. SCIENCE, 1992, 257 (5068) : 383 - 386
  • [5] Core structure of gp41 from the HIV envelope glycoprotein
    Chan, DC
    Fass, D
    Berger, JM
    Kim, PS
    [J]. CELL, 1997, 89 (02) : 263 - 273
  • [6] The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection
    Cocchi, F
    DeVico, AL
    GarzinoDemo, A
    Cara, A
    Gallo, RC
    Lusso, P
    [J]. NATURE MEDICINE, 1996, 2 (11) : 1244 - 1247
  • [7] Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry
    Datema, R
    Rabin, L
    Hincenbergs, M
    Moreno, MB
    Warren, S
    Linquist, V
    Rosenwirth, B
    Seifert, J
    McCune, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) : 750 - 754
  • [8] HIGHLY POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY THE BICYCLAM DERIVATIVE JM3100
    DE CLERCQ, E
    YAMAMOTO, N
    PAUWELS, R
    BALZARINI, J
    WITVROUW, M
    DEVREESE, K
    DEBYSER, Z
    ROSENWIRTH, B
    PEICHL, P
    DATEMA, R
    THORNTON, D
    SKERLJ, R
    GAUL, F
    PADMANABHAN, S
    BRIDGER, G
    HENSON, G
    ABRAMS, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) : 668 - 674
  • [9] Identification of a major co-receptor for primary isolates of HIV-1
    Deng, HK
    Liu, R
    Ellmeier, W
    Choe, S
    Unutmaz, D
    Burkhart, M
    DiMarzio, P
    Marmon, S
    Sutton, RE
    Hill, CM
    Davis, CB
    Peiper, SC
    Schall, TJ
    Littman, DR
    Landau, NR
    [J]. NATURE, 1996, 381 (6584) : 661 - 666
  • [10] HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5
    Dragic, T
    Litwin, V
    Allaway, GP
    Martin, SR
    Huang, YX
    Nagashima, KA
    Cayanan, C
    Maddon, PJ
    Koup, RA
    Moore, JP
    Paxton, WA
    [J]. NATURE, 1996, 381 (6584) : 667 - 673